Darder M C, Epstein Y M, Treiser S L, Comito C E, Rosenberg H S, Dzingala L
IVF New Jersey, Somerset 08873, USA.
Fertil Steril. 1996 Mar;65(3):578-82. doi: 10.1016/s0015-0282(16)58157-6.
To determine the effects of prior gravidity on hormonal parameters, medication regimen, oocyte parameters, fertilization, and clinical pregnancy rates (PRs) in donor and own oocyte cycles.
A retrospective study of 64 first-attempt ovum donor cycles and 102 first-attempt IVF and ZIFT cycles using own oocytes conducted during a 2.5-year time period. Analyses of covariance and t-tests using gravidity of oocyte source (gravida versus nulligravida) and controlling for sperm parameters were used to assess differences in hormonal, endometrial, medication, and demographic parameters and were performed separately for donor cycles and for own oocyte cycles.
Private fertility center.
In ovum donation cycles, oocyte parameters, medication administered, and hormonal parameters of 64 oocyte donors between the ages of 21 and 35, 34 of whom were never pregnant, i.e., nulligravida and 30 who had ever been pregnant, regardless of the outcome of that pregnancy, i.e., gravida, were studied. In own oocyte cycles, oocyte parameters, medication administered, and hormonal parameters of 102 women, 54 nulligravida and 48 gravida, between the ages of 23 and 44 were studied.
Medication requirements, hormonal response, seminal parameters, oocyte quality, fertilization, and clinical PRs.
For patients using their own oocytes, there were no significant differences in any of the parameters studied. In contrast, compared with their nulligravida counterparts, gravida oocyte donors had fewer poor quality oocytes, had more high quality oocytes that fertilized, had a higher proportion of their oocytes fertilize, and had a higher PR per transfer.
A prior history of gravidity is an important predictor of clinical pregnancy in donor oocyte cycles but not in cycles in which patients use their own oocytes. Oocyte recipients may wish to consider donor gravidity in selecting their donor.
确定既往妊娠史对供卵周期和自体卵周期中激素参数、用药方案、卵母细胞参数、受精情况及临床妊娠率的影响。
一项回顾性研究,对在2.5年时间内进行的64个首次尝试的供卵周期以及102个首次尝试的使用自体卵的体外受精(IVF)和输卵管内配子移植(ZIFT)周期进行研究。采用协方差分析和t检验,以卵母细胞来源的妊娠史(经产妇与未产妇)为变量,并控制精子参数,来评估激素、子宫内膜、用药及人口统计学参数的差异,分别对供卵周期和自体卵周期进行分析。
私立生育中心。
在供卵周期中,研究了64名年龄在21至35岁之间的供卵者的卵母细胞参数、用药情况及激素参数,其中34名从未怀孕,即未产妇,30名曾怀孕,无论妊娠结局如何,即经产妇。在自体卵周期中,研究了102名年龄在23至44岁之间的女性的卵母细胞参数、用药情况及激素参数,其中54名未产妇,48名经产妇。
用药需求、激素反应、精液参数、卵母细胞质量、受精情况及临床妊娠率。
对于使用自体卵的患者,所研究的任何参数均无显著差异。相比之下,与未产妇供卵者相比,经产妇供卵者的劣质卵母细胞较少,优质可受精卵母细胞较多,卵母细胞受精比例更高,每次移植的临床妊娠率也更高。
既往妊娠史是供卵周期临床妊娠的重要预测因素,但在患者使用自体卵的周期中并非如此。卵母细胞接受者在选择供卵者时可能希望考虑供卵者的妊娠史。